STAND. COM. REP. NO. 1683
RE: S.B. No. 1263
Honorable Scott K. Saiki
Speaker, House of Representatives
Thirtieth State Legislature
Regular Session of 2019
State of Hawaii
Your Committee on Health, to which was referred S.B. No. 1263, S.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT,"
begs leave to report as follows:
The purpose of this measure is to amend the Uniform Controlled Substances Act, chapter 329, Hawaii Revised Statutes, to:
(1) Update section 329-38(i) to be consistent with federal law by allowing for the use of either words or figures to indicate quantity on electronic prescriptions of controlled substances; and
(2) Make it consistent with amendments in the federal controlled substances law by including a Schedule V controlled substance used to treat certain childhood-onset epilepsy patients.
The Department of Public Safety, Queen's Health Systems, Kaiser Permanente Hawai‘i, Walgreen Co., and Epilepsy Foundation Hawaii testified in support of this measure. Akamai Cannabis Clinic and Hawaii Academy of Physician Assistants provided comments.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 1263, S.D. 1, and recommends that it pass Second Reading and be referred to your Committee on Judiciary.
Respectfully submitted on behalf of the members of the Committee on Health,
JOHN M. MIZUNO, Chair